In Other News

• Approved MS Drug Inhibits Replication of SARS-CoV-2 in Human Lung Cells and Fights Immune Reaction Killing COVID-19 Patients

• New COVID-19 Testing Method Delivers Accurate Results Without Using Reagents

• New Sensor Rapidly Detects COVID-19 Infection Status, Severity, and Immunity

• Quidel Receives FDA EUA for First Rapid Antigen Combination ABC Test for Influenza A+B and COVID-19

• LabCorp’s Innovative SARS-CoV-2 RNA Extraction Method Secures FDA Emergency Use Authorization

• Beckman Coulter Granted FDA EUA for COVID-19 Inflammatory Response Immunoassay

• COVID-19 Machine-Learning Algorithm Secures FDA Emergency Use Authorization

• Gilead’s Remdesivir (Veklury) to Be Reviewed by EU Regulator After COVID-19 Patients Report Acute Kidney Injury

• Enlivex Reports Positive Allocetra Trial Results in COVID-19 Patients in Severe/Critical Condition

• COVID 19 - Medela’s Portable Medical Surgical and Airway Suction Devices Offers Safer Alternative to Piped Vacuum Systems

• FDA-Approved Drug to Lower Blood Sugar Nearly Halves Mortality in Diabetic Patients Hospitalized With COVID-19

• Potential Micro-Magnetic Theranostic Measures COVID-19 Viral-Load with MRI

• Engineered RNA-Targeting Compounds Break COVID-19’s Clutch by Disabling SARS-CoV-2’s Replication Engine

• Some SARS-CoV-2 Antibodies Are More Protective Than Others in Preventing COVID-19 Reinfection, Finds Study

• New Diagnostic Tool Identifies and Treats COVID-19 Patients at Serious Risk of Developing Cytokine Storm

• Vivera Pharmaceuticals Launches Two New COVID-19 Diagnostic Tests for Detection of SARS-CoV-2 Antigens

• Moderna’s COVID-19 Vaccine Won’t Be Ready Until Spring of Next Year, Says CEO

• AstraZeneca’s COVID-19 Vaccine Study Being Investigated Further by US FDA; EU Regulator Starts “Rolling Review” to Expedite Approval

• AI Algorithm Detects COVID-19 in Lungs by Analyzing CT Scans With 90% Accuracy

• Regeneron's COVID-19 Antibody Cocktail Reduces Viral Levels and Speeds Recovery in Early Data

• Huge COVID-19 Testing Demand to Drive Global Point-of-Care Diagnostics Market to USD 11.7 Billion by 2024

• New, Portable Lab-on-a-Chip Identifies Concentration of COVID-19 Antibodies in Human Blood In 15 Minutes

• BD Receives CE Mark for Portable, Rapid Point-of-Care COVID-19 Antigen Test That Detects SARS-CoV-2 in 15 Minutes